Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Endoscopic Findings in a Mass Screening Program for Gastric Cancer in a High Risk Region - Guilan Province of Iran

  • Mansour-Ghanaei, Fariborz (Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences) ;
  • Sokhanvar, Homayoon (Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences) ;
  • Joukar, Farahnaz (Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences) ;
  • Shafaghi, Afshin (Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences) ;
  • Yousefi-Mashhour, Mahmud (Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences) ;
  • Valeshabad, Ali Kord (Students Scientific Research Center, Tehran University of Medical Sciences & National Elites Foundation) ;
  • Fakhrieh, Saba (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Aminian, Keyvan (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Ghorbani, Kambiz (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Taherzadeh, Zahra (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Sheykhian, Mohammad Reza (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Rajpout, Yaghoub (Division of Gastroenterology & Hepatology, Guilan University of Medical Sciences) ;
  • Mehrvarz, Alireza (Afrapathobiology Laboratory)
  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background & Objectives: Gastric cancer is a leading cause of cancer-related deaths in both sexes in Iran. This study was designed to assess upper GI endoscopic findings among people > 50 years targeted in a mass screening program in a hot-point region. Methods: Based on the pilot results in Guilan Cancer Registry study (GCRS), one of the high point regions for GC-Lashtenesha- was selected. The target population was called mainly using two methods: in rural regions, by house-house direct referral and in urban areas using public media. Upper GI endoscopy was performed by trained endoscopists. All participants underwent biopsies for rapid urea test (RUT) from the antrum and also further biopsies from five defined points of stomach for detection of precancerous lesions. In cases of visible gross lesions, more diagnostic biopsies were taken and submitted for histopathologic evaluation. Results: Of 1,394 initial participants, finally 1,382 persons (702 women, 680 men) with a mean age of $61.7{\pm}9.0$ years (range: 50-87 years) underwent upper GI endoscopy. H. pylori infection based on the RUT was positive in 66.6%. Gastric adenocarcinoma and squamous cell carcinoma of esophagus were detected in seven (0.5%) and one (0.07%) persons, respectively. A remarkable proportion of studied participants were found to have esophageal hiatal hernia (38.4%). Asymptomatic gastric masses found in 1.1% (15) of cases which were mostly located in antrum (33.3%), cardia (20.0%) and prepyloric area (20.0%). Gastric and duodenal ulcers were found in 5.9% (82) and 6.9% (96) of the screened population. Conclusion: Upper endoscopy screening is an effective technique for early detection of GC especially in high risk populations. Further studies are required to evaluate cost effectiveness, cost benefit and mortality and morbidity of this method among high and moderate risk population before recommending this method for the GC surveillance program at the national level.

Keywords

References

  1. Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.
  2. Choi KS, Kwak MS, Lee HY, et al (2009). Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev, 18,1390-8. https://doi.org/10.1158/1055-9965.EPI-08-0940
  3. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Version 2.0.IARC Cancer Base no 5. Lyon: IARC Press, (http://www-depdb.iarc.fr/globocan2002.htm ).
  4. Fock KM, Talley N, Moayyedi P, et al (2008). Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol, 23, 351-65. https://doi.org/10.1111/j.1440-1746.2008.05314.x
  5. Ghadimi R, Taheri H, Suzuki S, et al (2007). Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev, 16, 192-5. https://doi.org/10.1097/01.cej.0000220639.61717.67
  6. Gonzalez CA, Pera G, Agudo A, et al (2003). Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer, 107, 629-34. https://doi.org/10.1002/ijc.11426
  7. Green PH, O'Toole KM, Slonim D, Wang T, Weg A (1988). Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med, 85, 658-61. https://doi.org/10.1016/S0002-9343(88)80238-9
  8. Hussein NR(2010). Helicobacter pylori and gastric cancer in the Middle East: a new enigma? World J Gastroenterol, 16, 3226-34. https://doi.org/10.3748/wjg.v16.i26.3226
  9. Kang JM, Kim N, Yoo JY, et al (2008). The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter, 13, 146-56. https://doi.org/10.1111/j.1523-5378.2008.00592.x
  10. Khedmat H, Panahian M, Mashahdian M, et al (2011). Prognostic factors and survival in stomach cancer - analysis of 15 years of data from a referral hospital in Iran and evaluation of international variation. Onkologie, 34, 178-82. https://doi.org/10.1159/000327007
  11. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13,143-6.
  12. Lee HY, Park EC, Jun JK, Choi KS, Hahm MI (2010). Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol, 16, 245-50. https://doi.org/10.3748/wjg.v16.i2.245
  13. Lee KJ, Inoue M, Otani T, et al (2006). Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer, 118, 2315-21. https://doi.org/10.1002/ijc.21664
  14. Leung WK, Wu MS, Kakugawa Y, et al (2008). Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol, 9, 279-87. https://doi.org/10.1016/S1470-2045(08)70072-X
  15. Liou JM, Lin JT, Wang HP, et al (2005). The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc, 61, 819-25. https://doi.org/10.1016/S0016-5107(05)00366-4
  16. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
  17. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42. https://doi.org/10.1136/jcp.57.1.37
  18. Miyamoto A, Kuriyama S, Nishino Y, et al (2007). Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based study. Prev Med, 44, 12-9. https://doi.org/10.1016/j.ypmed.2006.07.016
  19. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med, 12, 15-23.
  20. Mousavi SM, Somi MH (2009). Gastric cancer in Iran 1966- 2006. Asian Pac J Cancer Prev, 10,407-12.
  21. Mousavi SM, Ramazani R, Davanloo M, et al (2008a). National Cancer Registry Report 2005-2006. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office.
  22. Mousavi SM, Alamolhoda AA, Gouya MM, Lickiss NJ (2008b). Implementation of comprehensive national cancer control program in Iran: an experience in a developing country. Ann Oncol, 19, 398-400.
  23. Mousavi SM (2007). Comprehensive National Cancer Control Program in Iran. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office.
  24. Mukoubayashi C, Yanaoka K, Ohata H, et al (2007). Serum pepsinogen and gastric cancer screening. Intern Med, 46, 261-6. https://doi.org/10.2169/internalmedicine.46.6181
  25. Murakami R, Tsukuma H, Ubukata T, et al (1990). Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer, 65, 1255-60. https://doi.org/10.1002/1097-0142(19900301)65:5<1255::AID-CNCR2820650536>3.0.CO;2-P
  26. Naghavi M, Jafari N ( 2007). Mortality views in 29 Provinces of Iran in 2004- Ministry of Health, Deputy for Health Directory, Research and Development Office, Tehran, Iran, (in Persian).
  27. Naghavi M (2006). Mortality views in 29 Provinces of Iran in 2004- Ministry of Health, Deputy for Health Directory, Res & Development Office, 111-91.
  28. Nakamura K, Ueyama T, Yao T, et al (1992). Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer, 70, 1030-7. https://doi.org/10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C
  29. Pakseresht M, Forman D, Malekzadeh R, et al (2011). Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control, 22, 725-36. https://doi.org/10.1007/s10552-011-9744-5
  30. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  31. Sadjadi A, Malekzadeh R, Derakhshan MH, et al(2003). Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8. https://doi.org/10.1002/ijc.11359
  32. Sadjadi A, Zahedi MJ, Darvish Moghadam S, et al (2007). The First population-based cancer survey in Kerman Province of Iran. Iranian J Publ Health, 36, 26-34.
  33. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, et al (2008). Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci, 53, 27-33. https://doi.org/10.1007/s10620-007-9817-1
  34. Stael VHC, Eriksson S, Huldt B, Hammar E (1991). Endoscopic screening during 17 years for gastric stump carcinoma: a prospective clinical trial. Scand J Gastroenterol, 26, 1020-6. https://doi.org/10.3109/00365529109003951
  35. The EUROGAST Study Group et al (1993). An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-62. https://doi.org/10.1016/0140-6736(93)90938-D
  36. Tusbono Y, Hisamichi S (2000). Screening for gastric cancer in Japan. Gastric Cancer, 3, 9-18. https://doi.org/10.1007/PL00011692
  37. Wang FW, Tu MS, Mar GY, et al (2011). Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World J Gastroenterol, 17, 1199-203. https://doi.org/10.3748/wjg.v17.i9.1199
  38. Yoshihara M, Hiyama T, Yoshida S, et al (2007). Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol, 42, 760-4. https://doi.org/10.1080/00365520601097351

Cited by

  1. Cost-effectiveness Outcomes of the National Gastric Cancer Screening Program in South Korea vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.5.2533
  2. Serum Gastrin and the Pepsinogen I/II Ratio as Markers for Diagnosis of Premalignant Gastric Lesions vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3931
  3. Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China vol.10, pp.12, 2015, https://doi.org/10.1371/journal.pone.0145097
  4. Does treatment of Helicobacter Pylori Infection Reduce Gastric Precancerous Lesions? vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1571
  5. Upper Gastrointestinal Tract Polyps: What Do We Know About Them? vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2999
  6. The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival vol.50, pp.3, 2016, https://doi.org/10.1097/MCG.0000000000000466
  7. High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults vol.12, pp.9, 2017, https://doi.org/10.1371/journal.pone.0184272
  8. Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry vol.18, pp.1, 2018, https://doi.org/10.1186/s12889-018-6119-9